Clarus Therapeutics starts dosing in Phase lll trial of jatenzo to treat hypogonadal

Clarus Therapeutics, a men's health specialty pharmaceutical company, has started dosing patients in a Phase lll clinical trial (inTUne) of jatenzo to treat hypogonadism in males.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news